Home Serum uric acid to albumin ratio and C-reactive protein as predictive biomarkers for chronic total occlusion and coronary collateral circulation quality
Article Open Access

Serum uric acid to albumin ratio and C-reactive protein as predictive biomarkers for chronic total occlusion and coronary collateral circulation quality

  • Yufei Zhao , Jianming Zhang , ErLi Yang , Juan Wu and Shouye Dong EMAIL logo
Published/Copyright: November 15, 2025

Abstract

Background

Coronary collateral circulation (CCC) plays a vital role in preserving myocardial perfusion in patients with chronic total occlusion (CTO). Reliable biomarkers for evaluating CCC are needed. This study aimed to investigate the combined diagnostic value of serum uric acid-to-albumin ratio (UAR) and C-reactive protein (CRP) in assessing the CCC status.

Methods

We enrolled 220 patients undergoing coronary angiography and categorized them into three groups: CTO (n = 80), coronary heart disease (CHD, n = 100), and controls (n = 40). Serum UAR and CRP levels were measured. Logistic regression and receiver operating characteristic curve analyses were performed to determine associations with CCC quality.

Results

UAR and CRP levels were significantly elevated in the CTO group compared to CHD and control groups. Among CTO patients, those with well-developed CCC had significantly lower UAR and CRP levels. Both biomarkers were identified as independent predictors of the CCC status. Combined use of CRP and UAR improved diagnostic specificity to 91.1%.

Conclusion

This is the first study to demonstrate the diagnostic utility of combining UAR and CRP for evaluating CCC in CTO patients. The dual-marker approach enhances diagnostic accuracy and may support more precise clinical decision-making in coronary artery disease.

1 Introduction

Coronary artery disease (CAD) remains a leading cause of cardiovascular mortality worldwide, characterized by atherosclerotic plaque formation and progressive arterial stenosis [1,2,3]. With population aging and lifestyle changes, the incidence of CAD continues to rise, posing substantial challenges to global healthcare systems [4,5,6]. Chronic total occlusion (CTO), the most advanced form of CAD, involves complete coronary artery obstruction for more than three months [7,8,9]. CTO significantly impairs myocardial perfusion, resulting in ischemia or infarction and adversely affecting patient quality of life and prognosis [10,11,12]. Despite advancements in interventional cardiology, CTO remains a clinical challenge, with low revascularization success, high restenosis rates, and variable outcomes [13,14,15].

Coronary collateral circulation (CCC) serves as an adaptive mechanism that maintains myocardial perfusion in the setting of coronary artery obstruction. Well-developed CCC can reduce ischemic burden, preserve myocardial function, and improve long-term outcomes [16,17,18]. The extent of CCC development is closely associated with survival after myocardial infarction, recovery of cardiac function, and overall prognosis [19,20]. Clinically, CCC evaluation is essential for guiding CTO management and predicting therapeutic response [21,22]. However, its formation is influenced by various factors, including genetics, metabolic status, and comorbid conditions [23], highlighting the need for reliable biomarkers to assess CCC status.

Recent advances in biomedical research have promoted the use of serum biomarkers in evaluating CTO and CCC [24]. Uric acid (UA), albumin (Alb), and C-reactive protein (CRP) have been studied for their pathophysiological relevance in cardiovascular disease [25,26]. UA is a marker of oxidative stress, which contributes to CAD progression [27,28]; decreased albumin reflects systemic inflammation and malnutrition [29], and elevated CRP indicates acute inflammatory activity [30]. Prior studies have shown that elevated UA levels are significantly associated with impaired CCC in patients with acute coronary syndrome, stable CAD, and CTO [3,31,32]. The UA-to-albumin ratio (UAR) has emerged as a composite biomarker integrating metabolic and inflammatory status [33]. However, the combined diagnostic value of UAR and CRP in assessing CCC remains underexplored.

Therefore, this study aimed to evaluate, for the first time, the combined utility of UAR and CRP in assessing CCC development in CTO patients. Based on clinical and biochemical data from 220 individuals undergoing coronary angiography, we investigated their potential as biomarkers to improve diagnostic accuracy and support personalized treatment strategies.

2 Materials and methods

2.1 Research subject

This study included patients who underwent coronary angiography at the First Affiliated Hospital of Jinzhou Medical University from January 2019 to December 2022 (Figure 1). Inclusion criteria were: age 18 years or older and complete baseline blood biochemistry data (including UA, albumin, CRP, triglycerides, etc.). The patients were divided into three groups: the CTO group (80 cases), where coronary angiography revealed at least one completely occluded vessel with an occlusion duration of more than three months; the coronary heart disease (CHD) group (100 cases), where angiography showed at least one vessel with more than 50% stenosis; and the normal control group (CON) (40 cases), where no significant stenosis was observed on angiography. The CHD group was included as an intermediate pathological state between normal coronary arteries and CTO, which helps to clarify the dynamic changes in UAR and CRP across different stages of CAD. This three-group comparison enhances the interpretive value of the study and supports the potential of UAR and CRP as stratified diagnostic biomarkers. Exclusion criteria included structural heart disease, malignant tumors, rheumatic or autoimmune diseases, liver or renal dysfunction, recent use of immunosuppressive drugs, neurodegenerative diseases, and recent acute inflammation or infection.

Figure 1 
                  Flowchart of the participant inclusion and exclusion processes. Note: CTO: chronic total occlusion; CHD: coronary heart disease (stenosis); CON: control.
Figure 1

Flowchart of the participant inclusion and exclusion processes. Note: CTO: chronic total occlusion; CHD: coronary heart disease (stenosis); CON: control.

All sensitive personal information (e.g., name, ID number) was anonymized and replaced with unique identification codes to ensure patient privacy. Data were stored in the hospital’s secure database, accessible only to core research team members, ensuring data security. The analysis results did not contain any personally identifiable information. This study was approved by the Clinical Ethics Committee of The Second Affiliated Hospital of Anhui Medical University (approved number: SL-YX(YS)2023-SZR 092), and informed consent was obtained from all participants. The study strictly adhered to the principles outlined in the Declaration of Helsinki [34].

2.2 Research methods

Patient information, including name, gender, age, height, weight, body mass index (BMI), and medical history (hypertension, diabetes, stroke, smoking history), was collected. Within 24 hours of admission, fasting venous blood samples were obtained in the early morning and analyzed using a whole blood automated analyzer to measure white blood cell count (WBC), hemoglobin (Hb), and platelet levels. Additionally, an automated chemiluminescence immunoassay analyzer was used to measure alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), glucose (Glu), UA, creatinine (CR), CRP, total cholesterol (TC), triglycerides (TG), total protein (TP), albumin (ALB), albumin/globulin ratio, and UAR. Coronary angiography was performed using the Judkins method, and collateral circulation was classified into Rentrop 0 to 3 levels based on the coronary angiogram findings [35]: Grade 0 indicates no visible collateral vessels, Grade 1 indicates some filling of the side branch, Grade 2 represents partial filling of the epicardial vessel in CTO, and Grade 3 indicates complete filling of the epicardial vessel.

2.3 Statistical analysis

In this study, all statistical analyses were performed using SPSS 22.0 software. Continuous variables with a normal distribution were expressed as mean ± standard deviation and compared between groups using t-tests or analysis of variance. Continuous variables with a non-normal distribution were expressed as the median and interquartile range, with group comparisons performed using the Mann–Whitney U test or Kruskal–Wallis test. Categorical variables were described as proportions, and group comparisons were conducted using the chi-square test (χ 2 test) or Fisher’s exact test. Normality tests were performed for all continuous variables, and Bonferroni correction was applied for multiple comparisons, with P < 0.05 considered statistically significant [36].

To explore the impact of CRP and UAR on CCC formation in CTO patients, binary logistic regression analysis was conducted to assess the independent predictive value of these biomarkers based on the correlation analysis. In the study, 80 CTO patients were divided into a low collateral circulation group (Rentrop grades 0–1) and a high collateral circulation group (Rentrop grades 2–3) according to the Rentrop grading. Collateral circulation formation (0 = low collateral circulation, 1 = high collateral circulation) was set as the dependent variable, while CRP, UA, and UAR were the primary independent variables. Variables with statistical significance (P < 0.05) were initially identified through univariate analysis and directly included in the regression model. The regression analysis employed the maximum likelihood estimation method, with results presented as odds ratios (OR) and their 95% confidence intervals (CI). The model’s goodness-of-fit was evaluated using the Hosmer–Lemeshow test, and model independence was validated through residual analysis and standardized coefficients to ensure the robustness of the results.

3 Results

3.1 Elevated biochemical markers in patients with CTO: Implications for pathophysiology and management

Baseline characteristics were compared among the CHD, CTO, and CON groups, as shown in Table 1. A total of 220 patients were included in this study, with 114 males (51.81%) and 106 females (48.19%), and a mean age of 63.35 ± 10.94 years. There were no statistically significant differences in age, gender, BMI, or histories of hypertension, diabetes, stroke, and smoking across the three groups, indicating comparable baseline characteristics.

Table 1

Baseline characteristics comparison among normal, coronary heart disease, and chronic total occlusion groups

Project CON group (n = 40) CHD group (n = 100) CTO group (n = 80) H/χ 2 value
Age (years) 66.00 (56.75, 69.00) 65.50 (57.25, 71.75) 68.00 (55.25, 74.00) 1.706
BMI (kg/m2) 22.92 (20.63, 26.29) 23.30 (20.72, 26.10) 22.77 (20.30, 25.29) 1.414
Male patients/cases (%) 19 51 52 4.779
History of hypertension/cases (%) 22 58 54 2.402
History of diabetes/cases (%) 12 21 28 4.473
History of stroke/cases (%) 1 12 6 2.826
Smoking history/cases (%) 6 24 27 2.232
WBC (*109) 6.39 ± 2.12 6.58 ± 2.04 6.43 ± 1.58 0.211
Hb (g/L) 131.00 (126.00, 137.50) 132.00 (124.25, 140.00) 130.00 (121.00, 140.00) 2.187
PLT (*109) 239.00 (202.25, 300.25) 221.00 (175.25, 264.50) 210.50 (174.25, 264.50) 5.352
ALT (U/L) 38.97 ± 49.57 36.88 ± 72.88 44.06 ± 80.99 0.221
AST (U/L) 54.25 ± 78.94 38.86 ± 72.14 50.46 ± 67.30 0.910
BUN (mmol/L) 7.16 ± 3.06 7.70 ± 5.00 8.08 ± 3.43 0.659
Glu (mmol/L) 5.06 (4.57, 5.89) 5.04 (4.47, 5.59)* 5.43 (4.72, 6.81)* 6.693
UA (µmol/L) 254.00 (192.50, 287.50) 291.50 (242.50, 329.75)* 328.50 (277.39, 390.00)*# 30.182
CR (µmol/L) 59.00 (52.25, 67.00) 66.00 (59.25, 72.00)* 67.00 (59.25, 72.00)* 15.088
CRP (mg/L) 2.98 ± 2.17 7.83 ± 9.90* 8.08 ± 3.43* -3.019
TC (mmol/L) 3.72 ± 0.92 4.12 ± 1.05 4.32 ± 1.64 2.953
TG (mmol/L) 1.51 ± 0.89 1.58 ± 0.75 2.28 ± 2.12*# 6.505
TP (g/L) 63.95 (60.33, 68.88) 64.15 (59.33, 68.70) 65.10 (60.08, 69.05) 0.768
ALB (g/L) 38.60 (35.90, 40.95) 35.88 (36.03, 41.75) 40.15 (36.35, 42.40) 2.895
Albumin/globulin ratio 1.52 (1.30, 7.12) 1.51 (1.33, 1.78) 1.52 (1.36, 1.67) 2.312
UAR 6.57 (5.12, 8.03) 7.55 (6.20, 8.75)* 8.30 (7.55, 9.97)*# 20.826

Note: CTO: chronic total occlusion; CHD: coronary heart disease; CON: control, BMI: body mass index, WBC: white blood cell, PLT: platelet, ALT: alanine aminotransferase, AST: aspartate aminotransferase, BUN: blood urea nitrogen, Glu: glucose, UA: uric acid, CR: creatinine, CRP: C-reactive protein, TC: total cholesterol, TG: triglyceride, TP: total protein, ALB: albumin, UAR: uric acid-to-albumin ratio,*p < 0.05 vs CON group; #p < 0.05 vs CHD group.

No significant differences were observed in several biochemical parameters, including WBC, Hb, PLT, ALT, AST, BUN, TC, TP, ALB, and the albumin/globulin ratio. The glucose level in the CTO group (5.43 mmol/L) was significantly higher than in the CON group (5.06 mmol/L, p = 0.03) (Figure 2a). The UA level in the CTO group (328.50 μmol/L) was significantly higher than in the CHD (291.50 μmol/L) and CON (254.00 μmol/L) groups (p < 0.001) (Figure 2b). Triglyceride levels were higher in the CTO group (2.28 mmol/L) than in the CHD and CON groups (p < 0.01) (Figure 2c). CRP levels were significantly elevated in the CTO and CHD groups compared to the CON group (p < 0.01) (Figure 2d). Creatinine levels in the CTO and CHD groups were higher than in the CON group (p < 0.01) (Figure 2e). UAR levels were also significantly increased in the CTO group (8.30) compared to the CHD group (7.55) and the CON group (6.57) (p < 0.001) (Figure 2f).

Figure 2 
                  Violin plot illustrating variances in baseline data metrics. Note: Comparison of pre-test results between the CTO (chronic total occlusion) group, CHD (coronary heart disease) group, and CON (control) group for (a) fasting blood glucose, (b) uric acid, (c) triglycerides, (d) C-reactive protein, (e) creatinine, and (f) urinary albumin-to-creatinine ratio. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 2

Violin plot illustrating variances in baseline data metrics. Note: Comparison of pre-test results between the CTO (chronic total occlusion) group, CHD (coronary heart disease) group, and CON (control) group for (a) fasting blood glucose, (b) uric acid, (c) triglycerides, (d) C-reactive protein, (e) creatinine, and (f) urinary albumin-to-creatinine ratio. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001.

3.2 Association of CRP and UAR levels with collateral circulation formation in CTO patients

Eighty CTO patients were categorized into the low collateral circulation group (Rentrop grades 0–1) and high collateral circulation group (Rentrop grades 2–3) based on the Rentrop classification (Table 2). There were no statistically significant differences in age, BMI, sex ratio, or histories of hypertension, diabetes, stroke, and smoking between the two groups (p > 0.05), indicating comparable baseline characteristics. No significant differences between the two groups were observed in WBC, Hb, PLT, ALT, AST, BUN, Glu, TC, TG, TP, or ALB levels. The high collateral circulation group had lower UA levels (303.50 μmol/L vs 344.00 μmol/L, p = 0.012), lower CRP levels (p = 0.001), and lower UAR values (7.22 vs 9.50, p = 0.001) compared to the low collateral group. Binary logistic regression analysis was performed on variables with significant differences. CRP was identified as an independent predictor of collateral circulation (OR = 0.717, 95% CI: 0.582–0.882, p = 0.002), as was UAR (OR = 0.550, 95% CI: 0.317–0.953, p = 0.033). UA was insignificant in the regression model (p = 0.317) (Table 3).

Table 2

Baseline data comparison of CTO patients with different levels of coronary collateral circulation

Project Lower limb circulation group (n = 46) Upper limb circulation group (n = 34) t/F value P value
Age (years) 65.02 ± 13.54 64.56 ± 10.06 0.175 0.861
BMI/(kg/m2) 22.51 (20.02, 26.51) 23.31 (20.13, 25.66) 0.168 0.851
Male patients/cases (%) 28 (60.87) 24 (70.59) 0.812 0.368
History of hypertension/case (%) 31 (67.39) 23 (67.64) 0.001 0.981
History of diabetes/cases (%) 19 (41.30) 9 (26.47) 1.891 0.169
History of stroke/cases (%) 3 (9.67) 3 (8.82) 0.149 0.699
Smoking history/cases (%) 18 9 1.401 0.236
WBC (*109) 5.79 (4.85, 7.40) 6.87 (5.55, 8.03) 1.830 0.067
Hb (g/L) 129.00 (120.00, 135.00) 133.00 (122.00, 139.00) 1.694 0.090
PLT (*109) 209.00 (176.50, 258.25) 512.50 (164.50, 259.00) 0.214 0.830
ALT (U/L) 44.41 ± 97.03 43.59 ± 53.53 0.049 0.961
AST (U/L) 50.70 ± 67.76 50.15 ± 67.69 0.360 0.972
BUN (mmol/L) 7.09 (5.49, 9.41) 7.95 (5.26, 10.13) 00.341 0.733
Glu (mmol/L) 6.01 ± 2.28 6.27 ± 2.16 0.515 0.608
UA (µmol/L) 344.00 (305.00, 393.00) 303.50 (238.50, 375.25) 2.501 0.012
CR (µmol/L) 65.50 (57.00, 71.25) 68.00 (64.00, 74.25) 1.300 0.193
CRP (mg/L) 8.04 ± 9.85 2.229 ± 2.07 3.347 0.001
TC (mmol/L) 4.13 ± 1.64 4.57 ± 1.61 1.121 0.230
TG (mmol/L) 2.63 ± 2.60 1.81 ± 1.04 1.946 0.056
TP (g/L) 67.10 (62.13, 69.80) 61.10 (65.43, 67.50) 1.956 0.050
ALB (g/L) 41.30 (37.10, 42.70) 38.60 (35.68, 41.90) 1.538 0.124
Albumin/globulin ratio 1.53 (1.38, 1.66) 1.49 (1.29, 1.69) 0.540 0.089
UAR 9.50 (9.11, 10.27) 7.22 (6.00, 8.74) 3.337 0.001

Note: CTO: chronic total occlusion, BMI: body mass index, WBC: white blood cell, PLT: platelet, ALT: alanine aminotransferase, AST: aspartate aminotransferase, BUN: blood urea nitrogen, Glu: glucose, UA: uric acid, CR: creatinine, CRP: C-reactive protein, TC: total cholesterol, TG: triglyceride, TP: total protein, ALB: albumin, And UAR: uric acid-to-albumin ratio.

Table 3

Binary logistic regression analysis of factors influencing collateral circulation in CTO patients

Project CON group (n = 40) CHD group (n = 100) CTO group (n = 80) H2 value P value
CRP −0.559 0.106 9.886 0.717 (0.582–00.882) 0.002
UA 0.008 0.008 1.001 1.008 (0.993–1.023) 0.317
UAR −0.559 0.281 4.548 00.550 (0.317–0.953) 0.033

Note: UA: uric acid, CRP: C-reactive protein, UAR: uric acid-to-albumin ratio, CTO: chronic total occlusion, CON: control group, and CHD: coronary heart disease.

3.3 Predictive values of serum CRP and UAR for collateral circulation in patients with CTO

Receiver operating characteristic (ROC) curves were constructed for CTO patients based on high collateral circulation. The results revealed that the area under the ROC curve for CRP was 0.777 (95% CI 0.223–0.324), with an optimal cutoff value of 3.19 mg/L, sensitivity of 66.70%, and specificity of 79.40%. The area under the ROC curve for UAR was 0.720 (95% CI 0.161–0.399), with an optimal cutoff value of 8.74, sensitivity of 80.00%, and specificity of 76.50% (Figure 3a). When both biomarkers were used for diagnosis, the combined area under the ROC curve was 0.844 (95% CI 0.759–0.928, P < 0.001), with an optimal cutoff value of 0.61 mg/L, sensitivity of 64.70%, and specificity of 91.10% (Figure 3b).

Figure 3 
                  ROC curves of the logistic regression model. Note: (a) ROC curve for serum CRP and UAR in predicting the presence of CCC in CTO patients; (b) ROC curve for the combined prediction of CCC in CTO patients using serum CRP and UAR. CRP: C-reactive protein; CTO: chronic total occlusion; CHD: coronary heart disease (stenosis); CON: control; UAR: uric acid-to-albumin ratio.
Figure 3

ROC curves of the logistic regression model. Note: (a) ROC curve for serum CRP and UAR in predicting the presence of CCC in CTO patients; (b) ROC curve for the combined prediction of CCC in CTO patients using serum CRP and UAR. CRP: C-reactive protein; CTO: chronic total occlusion; CHD: coronary heart disease (stenosis); CON: control; UAR: uric acid-to-albumin ratio.

4 Discussion

In the research field of cardiovascular diseases, studies on serum UAR and CRP as risk factors have been increasing [37,38]. Previous studies have indicated that UA, an oxidative stress marker, is closely associated with various cardiovascular events [39,40]. Furthermore, as a negative acute-phase protein, albumin is widely reported to decrease under inflammatory conditions [41,42,43]. As a sensitive inflammation marker, CRP is crucial in predicting cardiovascular diseases [42,44,45]. In comparison to previous studies, our research, for the first time, establishes a connection between UAR and CCC in CTO patients, suggesting UAR as a novel biomarker for evaluating the collateral circulation status of CTO patients. It differs from prior literature that solely focused on UA or albumin as assessment indicators [37], providing a more comprehensive biochemical parameter analysis in our study.

Our study results demonstrate that UAR is significantly lower in the high collateral circulation group than in the low collateral circulation group, indicating that CTO patients with lower UAR may have better collateral circulation formation. The significant increase in UAR and CRP levels in the CTO group may reflect the combined effect of inflammation and oxidative stress in CTO patients. UA, as a marker of oxidative stress, may be elevated due to purine metabolism disorders, which could further exacerbate the progression of coronary atherosclerosis in CTO patients [26]. This finding is consistent with recent studies suggesting the dual role UA might play in cardiovascular health [46,47,48]. However, unlike other studies predominantly concentrating on the impact of UA at a single level [39], our research offers a new perspective by combining UA and albumin ratio to evaluate this relationship. Furthermore, our study further explores the connection between UAR and CTO and CCC formation, filling gaps in prior research.

In addition, CRP levels are closely associated with CTO and the formation of CCC. As a marker of the inflammatory response, elevated CRP may impair collateral vessel development by inhibiting endothelial cell function or enhancing vascular wall inflammation [49]. This finding is consistent with previous studies identifying CRP as a key inflammatory marker in cardiovascular disease [42,45,50]. While most existing research has focused on the relationship between CRP and cardiovascular event risk, our study further expands its potential clinical application in assessing collateral circulation in CTO patients [41,51,52]. Both CRP and UAR demonstrate good diagnostic value in predicting collateral vessel formation in CTO patients. Although CRP alone performs slightly better, its combined use significantly enhances diagnostic accuracy, improving sensitivity and specificity. Therefore, the combined measurement of CRP and UAR may offer a more reliable basis for evaluating CCC development in CTO patients, aiding in risk assessment and supporting individualized treatment strategies.

TG levels in CTO patients may aggravate coronary atherosclerosis and further impair collateral circulation formation, highlighting the role of lipid metabolism disorders in CTO pathophysiology [53]. Likewise, UAR was significantly higher in CTO patients, suggesting the combined influence of inflammation and metabolic dysfunction. As UAR reflects decreased albumin and elevated UA, impacting the disease state, its elevation may be clinically relevant [33]. Our findings show that combining UAR and CRP improves CTO and collateral circulation status diagnostic specificity. It offers a more precise tool for risk stratification and treatment planning. While prior studies have examined UAR and CRP individually as cardiovascular risk indicators, few have assessed their combined utility [54,55]. Our results suggest that their joint application may enhance clinical decision-making and support the broader use of these biomarkers in managing CTO, potentially improving diagnostic and prognostic outcomes.

This study identifies UAR and CRP as risk factors for the formation of CCC in patients with CTO, contributing to cardiovascular research and offering new tools for clinical risk assessment. These markers may aid in evaluating collateral circulation and guiding personalized treatment. However, limitations such as a small sample size and a single-center design may affect generalizability. UAR and CRP levels may also be influenced by metabolic disorders, chronic inflammation, or medications, highlighting the need to control for confounding factors in future research. Larger multicenter studies are needed to validate these findings and explore combined biomarker approaches to improve the diagnosis and treatment of CTO and CCC. Proteomic methods, such as those used in the MESA study [56], may help identify additional relevant biomarkers. The mechanisms by which UAR and CRP affect CCC development remain unclear. While hyperuricemia may be linked to hypoxia-induced purine metabolism in poorly perfused tissues, further studies are needed to clarify the molecular pathways. Future research should also examine the temporal dynamics of these biomarkers and their variability across disease stages and populations to support advances in precision cardiovascular medicine. Although CCC is typically assessed via invasive angiography at the time of CTO diagnosis, the added diagnostic value of UAR and CRP at this stage remains uncertain. As an exploratory study, our findings demonstrate for the first time that their combination can effectively predict CCC quality, offering a new direction for non-invasive risk assessment. Given the increasing use of coronary CT angiography (CTCA) in the early evaluation of CAD, validating the predictive value of these biomarkers in this setting could enable earlier identification of patients with poor CCC. Integrating serum markers with radiomics and artificial intelligence may further advance the development of a non-invasive, precision assessment system for CCC.

5 Conclusion

This study preliminarily reveals the potential value of combining serum CRP and UAR as biomarkers for predicting CCC status in patients with CTO. The findings reveal that elevated CRP and UAR levels are independent risk factors for impaired collateral formation, and their combined assessment can significantly improve diagnostic specificity. These results indicate that CRP and UAR are closely associated with CCC formation but do not fully reflect its complexity, suggesting that collateral formation is a multifactorial process (Figure 4). This study provides a foundation for integrating these biomarkers into clinical practice to better assess cardiovascular risk and prognosis in CTO patients. Although CCC is currently assessed by invasive angiography, future validation of CRP and UAR in non-invasive settings such as CTCA may enable early identification of patients with poor CCC, supporting risk stratification and personalized treatment. Larger, multi-center studies are needed to confirm these findings and further explore the mechanisms underlying CCC development.

Figure 4 
               Exploring the role of uric acid/albumin ratio and CRP levels in collateral circulation formation in CTO. Note: CRP: C-reactive protein; CTO: chronic total occlusion; UAR: uric acid-to-albumin ratio; and CCC: coronary collateral circulation.
Figure 4

Exploring the role of uric acid/albumin ratio and CRP levels in collateral circulation formation in CTO. Note: CRP: C-reactive protein; CTO: chronic total occlusion; UAR: uric acid-to-albumin ratio; and CCC: coronary collateral circulation.


tel: +86-15399688766

Acknowledgments

None.

  1. Funding information: This work was supported by a grant from the 2022 Anhui Research Preparation Program Project (No. 2022AH050771).

  2. Author contributions: Yufei Zhao conceived and designed the study. Juan Wu and Jianming Zhang performed the experiments. Erli Yang analyzed the data. Shouye Dong and Yufei Zhao wrote the manuscript. All authors reviewed and approved the final version of the manuscript.

  3. Conflict of interest: The author declares no conflict of interest.

  4. Data availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

[1] Huang F. Is a previously or currently reduced testosterone level in male patients with type 2 diabetes mellitus a risk factor for the development of coronary artery disease? a systematic review and meta-analysis. Diabetes Ther. 2018;9:1061–72.10.1007/s13300-018-0415-3Search in Google Scholar PubMed PubMed Central

[2] Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization. J Am Coll Cardiol. 2022;79:e21–e129.10.1016/j.jacc.2021.09.006Search in Google Scholar PubMed

[3] Golub IS, Termeie OG, Kristo S, Schroeder LP, Lakshmanan S, Shafter AM, et al. Major global coronary artery calcium guidelines. JACC: Cardiovasc Imaging. 2023;16:98–117.10.1016/j.jcmg.2022.06.018Search in Google Scholar PubMed

[4] Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease. Circulation. 2021;143:1157–72.10.1161/CIRCULATIONAHA.120.050686Search in Google Scholar PubMed PubMed Central

[5] Marnell CS, Bick A, Natarajan P. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol. 2021;161:98–105.10.1016/j.yjmcc.2021.07.004Search in Google Scholar PubMed PubMed Central

[6] Zuo X, Li X, Tang K, Zhao R, Wu M, Wang Y, et al. Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2023;14:1183–98.10.1002/jcsm.13221Search in Google Scholar PubMed PubMed Central

[7] Stone PH, Libby P, Boden WE. Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management – the plaque hypothesis. JAMA Cardiol. 2023;8:192.10.1001/jamacardio.2022.3926Search in Google Scholar PubMed PubMed Central

[8] Cury RC, Leipsic J, Abbara S, Achenbach S, Berman D, Bittencourt M, et al. CAD-RADSTM 2.0–2022 coronary artery disease-reporting and data system. J Cardiovasc Comput Tomogr. 2022;16:536–57.10.1016/j.jcct.2022.07.002Search in Google Scholar PubMed

[9] Onnis C, Virmani R, Kawai K, Nardi V, Lerman A, Cademartiri F, et al. Coronary artery calcification: current concepts and clinical implications. Circulation. 2024;149:251–66.10.1161/CIRCULATIONAHA.123.065657Search in Google Scholar PubMed PubMed Central

[10] Vaidya Y, Cavanaugh SM, Dhamoon AS. Myocardial stunning and hibernation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.Search in Google Scholar

[11] Iftikhar SF, Bishop MA, Hu P. Complex coronary artery lesions. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.Search in Google Scholar

[12] Leite L, Campos G, Silva R, Jorge E, Oliveira-Santos M, Gomes A, et al. The association of collaterals with myocardial ischemia and viability in chronic total occlusions. Int J Cardiovasc Imaging. 2022;39:843–51.10.1007/s10554-022-02772-zSearch in Google Scholar PubMed

[13] Fagu A, Berger T, Pingpoh C, Kondov S, Kreibich M, Minners J, et al. In-hospital outcomes following surgical revascularization of chronic total coronary occlusions. Medicina. 2023;59:1967.10.3390/medicina59111967Search in Google Scholar PubMed PubMed Central

[14] Sanchez-Jimenez E, El-Mokdad R, Chaddad R, Cortese B. Drug-coated balloon for the management of coronary chronic total occlusions. Rev Cardiovasc Med. 2022;23(2):42. 10.31083/j.rcm2302042.Search in Google Scholar PubMed

[15] Allana SS, Kostantinis S, Rempakos A, Simsek B, Karacsonyi J, Alexandrou M, et al. The retrograde approach to chronic total occlusion percutaneous coronary interventions. JACC: Cardiovasc Interventions. 2023;16:2748–62.10.1016/j.jcin.2023.08.031Search in Google Scholar PubMed

[16] Bhasin D, Shrimanth YS, Sharma YP, Panda P. Vieussens’ arterial ring. J Invasive Cardiol. 2022;34:E343–4.10.25270/jic/21.00390Search in Google Scholar PubMed

[17] Nepal S, Annamaraju P. Coronary arteriovenous fistula. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.Search in Google Scholar

[18] Achim A, Johnson NP, Liblik K, Burckhardt A, Krivoshei L, Leibundgut G. Coronary steal: how many thieves are out there? Eur Heart J. 2023;44:2805–14.10.1093/eurheartj/ehad327Search in Google Scholar PubMed

[19] Zhou H, Huang YS, Zhao Y-T, Zhang C-H, Wang H, Yang X-Y, et al. Clinical and electrocardiographic features in acute total left main coronary artery occlusion without collateral circulation. J Electrocardiol. 2023;76:79–84.10.1016/j.jelectrocard.2022.11.005Search in Google Scholar PubMed

[20] Calvão J, Braga M, Brandão M, Campinas A, Alexandre A, Amador A, et al. Acute total occlusion of the unprotected left main coronary artery: Patient characteristics and outcomes. Rev Port de Cardiol. 2023;42:723–9.10.1016/j.repc.2022.11.007Search in Google Scholar PubMed

[21] Alam MK, Alfawzan AA, Srivastava KC, Shrivastava D, Ganji KK, Manay SM. Craniofacial morphology in Apert syndrome: a systematic review and meta-analysis. Sci Rep. 2022;12(1):5708. 10.1038/s41598-022-09764-y.Search in Google Scholar PubMed PubMed Central

[22] Kim Y. The association between red, processed and white meat consumption and risk of pancreatic cancer: a meta-analysis of prospective cohort studies. Cancer Causes Control. 2023;34:569–81.10.1007/s10552-023-01698-8Search in Google Scholar PubMed

[23] Hao X, Wang S, Jiang C, Zhang J, Fan Y, Pang J, et al. The relation between plasma miR-126 levels and cerebral collateral circulation in patients with intracranial arterial stenosis. Neurol Neurochir Pol. 2021;55:281–8.10.5603/PJNNS.a2021.0019Search in Google Scholar PubMed

[24] Kang MS, Kim SY, Park SW, Byon IS, Kwon HJ. Association between capillary congestion and macular edema recurrence in chronic branch retinal vein occlusion through quantitative analysis of OCT angiography. Sci Rep. 2021;11(1):19886. 10.1038/s41598-021-99429-z.Search in Google Scholar PubMed PubMed Central

[25] Li Z, Kadian S, Mishra RK, Huang T, Zhou C, Liu S, et al. Electrochemical detection of cholesterol in human biofluid using microneedle sensor. J Mater Chem B. 2023;11:6075–81.10.1039/D2TB02142KSearch in Google Scholar

[26] Afrose D, Chen H, Ranashinghe A, Liu C, Henessy A, Hansbro PM, et al. The diagnostic potential of oxidative stress biomarkers for preeclampsia: systematic review and meta-analysis. Biol Sex Differ. 2022;13(1):26. 10.1186/s13293-022-00436-0.Search in Google Scholar PubMed PubMed Central

[27] Du K, Zhou Q, Wang Z, Mo C, Dong W, Wei N, et al. Polydatin ameliorates inflammation and oxidative stress associated with MSU-induced gouty arthritis in mice by regulating PPAR-γ and ferritin activation. Life Sci. 2023;326:121766.10.1016/j.lfs.2023.121766Search in Google Scholar PubMed

[28] Zhou Y, Chen M, Zheng J, Shui X, He Y, Luo H, et al. Insights into the relationship between serum uric acid and pulmonary hypertension (Review). Mol Med Rep. 2023;29(1):10. 10.3892/mmr.2023.13133.Search in Google Scholar PubMed PubMed Central

[29] Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, et al. Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106. Jpn J Clin Oncol. 2023;53:704–13.10.1093/jjco/hyad044Search in Google Scholar PubMed PubMed Central

[30] Gyawali P, Shrestha H, Pant V, Risal P, Gautam S. C-reactive protein to albumin ratio among patients admitted to intensive care unit of a tertiary care hospital: a descriptive crosssectional study. J Nepal Med Assoc. 2021;59:1247–51.10.31729/jnma.7047Search in Google Scholar PubMed PubMed Central

[31] Duran M, Ornek E, Murat SN, Turfan M, Vatankulu MA, Ocak A, et al. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2011;63:472–5.10.1177/0003319711422433Search in Google Scholar PubMed

[32] Uysal OK, Sahin DY, Duran M, Turkoglu C, Yıldırım A, Elbasan Z, et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology. 2013;65:227–31.10.1177/0003319713500706Search in Google Scholar PubMed

[33] Toprak K, Yılmaz R, Kaplangoray M, Memioğlu T, İnanır M, Akyol S, et al. Comparison of the effect of uric acid/albumin ratio on coronary colleteral circulation with other inflammation-based markers in stable coronary artery disease patients. Perfusion. 2023;39:1440–52.10.1177/02676591231202105Search in Google Scholar PubMed

[34] Lin G, Li J, Chen K, Wang A, Guo C. Circ_0000854 regulates the progression of hepatocellular carcinoma through miR-1294/IRGQ axis. Clin Immunol. 2022;238:109007.10.1016/j.clim.2022.109007Search in Google Scholar PubMed

[35] Chen S, Li L, Wu Z, Liu Y, Li F, Huang K, et al. SerpinG1: A novel biomarker associated with poor coronary collateral in patients with stable coronary disease and chronic total occlusion. JAHA. 2022;11(24):e027614. 10.1161/jaha.122.027614.Search in Google Scholar

[36] Li X, Zhu J, Zhong Y, Liu C, Yao M, Sun Y, et al. Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus. eBioMedicine. 2022;77:103857.10.1016/j.ebiom.2022.103857Search in Google Scholar PubMed PubMed Central

[37] Şaylık F, Çınar T, Selçuk M, Tanboğa İH. A Relação entre a Relação Ácido Úrico/Albumina e a Espessura Média-Intimal da Carótida em Pacientes com Hipertensão. Arq Bras Cardiol. 2023;120(5):e20220819. 10.36660/abc.20220819.Search in Google Scholar PubMed PubMed Central

[38] Selçuk M, Çınar T, Şaylık F, Akbulut T, Asal S, Çiçek V, et al. Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-elevation myocardial Infarction. Rev Invest Clin. 2022;74:156–64.10.24875/RIC.22000072Search in Google Scholar PubMed

[39] Del Pinto R, Viazzi F, Pontremoli R, Ferri C, Carubbi F, Russo E. The URRAH study. Panminerva Med. 2021;63(4):416–23. 10.23736/s0031-0808.21.04357-3.Search in Google Scholar PubMed

[40] Burnier M. Gout and hyperuricaemia: modifiable cardiovascular risk factors? Front Cardiovasc Med. 2023;10:1190069. 10.3389/fcvm.2023.1190069.Search in Google Scholar PubMed PubMed Central

[41] Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401:1293–301.10.1016/S0140-6736(23)00215-5Search in Google Scholar PubMed

[42] Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. SemArthritis Rheumatism. 2021;51:219–29.10.1016/j.semarthrit.2020.11.005Search in Google Scholar PubMed

[43] Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022;102:24–39.10.1016/j.ejim.2022.05.004Search in Google Scholar PubMed

[44] Suneson K, Lindahl J, Chamli Hårsmar S, Söderberg G, Lindqvist D. Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions. IJMS. 2021;22:1640.10.3390/ijms22041640Search in Google Scholar PubMed PubMed Central

[45] Dix C, Zeller J, Stevens H, Eisenhardt SU, Shing KSCT, Nero TL, et al. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol. 2022;13:1002652. 10.3389/fimmu.2022.1002652.Search in Google Scholar PubMed PubMed Central

[46] Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 2022;54:52–61.10.1038/s41588-021-00968-ySearch in Google Scholar PubMed

[47] Li B, Chen L, Hu X, Tan T, Yang J, Bao W, et al. Association of Serum uric acid with all-cause and cardiovascular mortality in diabetes. Diabetes Care. 2022;46:425–33.10.2337/dc22-1339Search in Google Scholar PubMed

[48] Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. IJMS. 2021;22:9221.10.3390/ijms22179221Search in Google Scholar PubMed PubMed Central

[49] Nacar AB, Erayman A, Kurt M, Buyukkaya E, Karakaş MF, Akcay AB, et al. The relationship between coronary collateral circulation and neutrophil/lymphocyte ratio in patients with coronary chronic total occlusion. Med Princ Pract. 2014;24:65–9.10.1159/000365734Search in Google Scholar PubMed PubMed Central

[50] Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021;13:2878.10.3390/nu13082878Search in Google Scholar PubMed PubMed Central

[51] Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease. J Am Coll Cardiol. 2023;82:648–60.10.1016/j.jacc.2023.05.055Search in Google Scholar PubMed

[52] Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Role of bempedoic acid in clinical practice. Cardiovasc Drugs Ther. 2021;35:853–64.10.1007/s10557-021-07147-5Search in Google Scholar PubMed PubMed Central

[53] Levy‐Hirsch L. Transferable skills from ECC career led to managing director role in startup business. Vet Rec. 2023;193(4):ii–iii. 10.1002/vetr.3402.Search in Google Scholar PubMed

[54] Li S, Chen H, Zhou L, Cui H, Liang S, Li H. The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention. ScJ Clin Lab Invest. 2022;82:304–10.10.1080/00365513.2022.2084698Search in Google Scholar PubMed

[55] Sultana S, Prakash VR, Karthikeyan A, Kulkarni A, Shaikh MA, GC S. Evaluation of uric acid to albumin ratio as a marker of coronary artery disease severity in acute coronary syndrome: a cross-sectional study. Cureus. 2023;15(11):e49454. 10.7759/cureus.49454.Search in Google Scholar PubMed PubMed Central

[56] Bakhshi H, Michelhaugh SA, Bruce SA, Seliger SL, Qian X, Ambale Venkatesh B, et al. Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis. eBioMedicine. 2023;90:104490.10.1016/j.ebiom.2023.104490Search in Google Scholar PubMed PubMed Central

Received: 2024-07-04
Revised: 2025-09-10
Accepted: 2025-09-10
Published Online: 2025-11-15

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
  3. Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study
  4. Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway
  5. Risk factors for severe adverse drug reactions in hospitalized patients
  6. Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing
  7. Development and validation of headspace gas chromatography with a flame ionization detector method for the determination of ethanol in the vitreous humor
  8. CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
  9. Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia
  10. Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
  11. Comparison of the effectiveness of nurse-led preoperative counseling and postoperative follow-up care vs standard care for patients with gastric cancer
  12. Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis
  13. Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
  14. Association between statin administration and outcome in patients with sepsis: A retrospective study
  15. Exploration of the association between estimated glucose disposal rate and osteoarthritis in middle-aged and older adults: An analysis of NHANES data from 2011 to 2018
  16. A comparative analysis of the binary and multiclass classified chest X-ray images of pneumonia and COVID-19 with ML and DL models
  17. Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function
  18. Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
  19. Serum PM20D1 levels are associated with nutritional status and inflammatory factors in gastric cancer patients undergoing early enteral nutrition
  20. Hydromorphone reduced the incidence of emergence agitation after adenotonsillectomy in children with obstructive sleep apnea: A randomized, double-blind study
  21. Vitamin D replacement therapy may regulate sleep habits in patients with restless leg syndrome
  22. The first-line antihypertensive nitrendipine potentiated the therapeutic effect of oxaliplatin by downregulating CACNA1D in colorectal cancer
  23. Health literacy and health-related quality of life: The mediating role of irrational happiness
  24. Modulatory effects of Lycium barbarum polysaccharide on bone cell dynamics in osteoporosis
  25. Mechanism research on inhibition of gastric cancer in vitro by the extract of Pinellia ternata based on network pharmacology and cellular metabolomics
  26. Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study
  27. Clinical analysis of ten cases of HIV infection combined with acute leukemia
  28. Investigating the cardioprotective potential of quercetin against tacrolimus-induced cardiotoxicity in Wistar rats: A mechanistic insights
  29. Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis
  30. Diagnostic value of ratio of blood inflammation to coagulation markers in periprosthetic joint infection
  31. Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
  32. Core muscle strength and stability-oriented breathing training reduces inter-recti distance in postpartum women
  33. The ERAS nursing care strategy for patients undergoing transsphenoidal endoscopic pituitary tumor resection: A randomized blinded controlled trial
  34. The serum IL-17A levels in patients with traumatic bowel rupture post-surgery and its predictive value for patient prognosis
  35. Impact of Kolb’s experiential learning theory-based nursing on caregiver burden and psychological state of caregivers of dementia patients
  36. Analysis of serum NLR combined with intraoperative margin condition to predict the prognosis of cervical HSIL patients undergoing LEEP surgery
  37. Commiphora gileadensis ameliorate infertility and erectile dysfunction in diabetic male mice
  38. The correlation between epithelial–mesenchymal transition classification and MMP2 expression of circulating tumor cells and prognosis of advanced or metastatic nasopharyngeal carcinoma
  39. Tetrahydropalmatine improves mitochondrial function in vascular smooth muscle cells of atherosclerosis in vitro by inhibiting Ras homolog gene family A/Rho-associated protein kinase-1 signaling pathway
  40. A cross-sectional study: Relationship between serum oxidative stress levels and arteriovenous fistula maturation in maintenance dialysis patients
  41. A comparative analysis of the impact of repeated administration of flavan 3-ol on brown, subcutaneous, and visceral adipose tissue
  42. Identifying early screening factors for depression in middle-aged and older adults: A cohort study
  43. Perform tumor-specific survival analysis for Merkel cell carcinoma patients undergoing surgical resection based on the SEER database by constructing a nomogram chart
  44. Unveiling the role of CXCL10 in pancreatic cancer progression: A novel prognostic indicator
  45. High-dose preoperative intraperitoneal erythropoietin and intravenous methylprednisolone in acute traumatic spinal cord injuries following decompression surgeries
  46. RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation
  47. Impact of peripheral conditioning on reperfusion injury following primary percutaneous coronary intervention in diabetic and non-diabetic STEMI patients
  48. Clinical efficacy of azacitidine in the treatment of middle- and high-risk myelodysplastic syndrome in middle-aged and elderly patients: A retrospective study
  49. The effect of ambulatory blood pressure load on mitral regurgitation in continuous ambulatory peritoneal dialysis patients
  50. Expression and clinical significance of ITGA3 in breast cancer
  51. Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy
  52. rSIG combined with NLR in the prognostic assessment of patients with multiple injuries
  53. Toxic metals and metalloids in collagen supplements of fish and jellyfish origin: Risk assessment for daily intake
  54. Exploring causal relationship between 41 inflammatory cytokines and marginal zone lymphoma: A bidirectional Mendelian randomization study
  55. Gender beliefs and legitimization of dating violence in adolescents
  56. Effect of serum IL-6, CRP, and MMP-9 levels on the efficacy of modified preperitoneal Kugel repair in patients with inguinal hernia
  57. Effect of smoking and smoking cessation on hematological parameters in polycythemic patients
  58. Pathogen surveillance and risk factors for pulmonary infection in patients with lung cancer: A retrospective single-center study
  59. Necroptosis of hippocampal neurons in paclitaxel chemotherapy-induced cognitive impairment mediates microglial activation via TLR4/MyD88 signaling pathway
  60. Celastrol suppresses neovascularization in rat aortic vascular endothelial cells stimulated by inflammatory tenocytes via modulating the NLRP3 pathway
  61. Cord-lamina angle and foraminal diameter as key predictors of C5 palsy after anterior cervical decompression and fusion surgery
  62. GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma
  63. Influencing factors of false lumen thrombosis in type B aortic dissection: A single-center retrospective study
  64. MZB1 regulates the immune microenvironment and inhibits ovarian cancer cell migration
  65. Integrating experimental and network pharmacology to explore the pharmacological mechanisms of Dioscin against glioblastoma
  66. Trends in research on preterm birth in twin pregnancy based on bibliometrics
  67. Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
  68. Single-cell transcriptomic analysis identifies a stress response Schwann cell subtype
  69. Acute pancreatitis risk in the diagnosis and management of inflammatory bowel disease: A critical focus
  70. Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients
  71. Interleukin-37 mediates the anti-oral tumor activity in oral cancer through STAT3
  72. CA199 and CEA expression levels, and minimally invasive postoperative prognosis analysis in esophageal squamous carcinoma patients
  73. Efficacy of a novel drainage catheter in the treatment of CSF leak after posterior spine surgery: A retrospective cohort study
  74. Comprehensive biomedicine assessment of Apteranthes tuberculata extracts: Phytochemical analysis and multifaceted pharmacological evaluation in animal models
  75. Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study
  76. Dopamine attenuates ethanol-induced neuronal apoptosis by stimulating electrical activity in the developing rat retina
  77. Correlation between albumin levels during the third trimester and the risk of postpartum levator ani muscle rupture
  78. Factors associated with maternal attention and distraction during breastfeeding and childcare: A cross-sectional study in the west of Iran
  79. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments
  80. The law on oncological oblivion in the Italian and European context: How to best uphold the cancer patients’ rights to privacy and self-determination?
  81. The prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and prognostic nutritional index for survival in patients with colorectal cancer
  82. Factors affecting the measurements of peripheral oxygen saturation values in healthy young adults
  83. Comparison and correlations between findings of hysteroscopy and vaginal color Doppler ultrasonography for detection of uterine abnormalities in patients with recurrent implantation failure
  84. The effects of different types of RAGT on balance function in stroke patients with low levels of independent walking in a convalescent rehabilitation hospital
  85. Causal relationship between asthma and ankylosing spondylitis: A bidirectional two-sample univariable and multivariable Mendelian randomization study
  86. Correlations of health literacy with individuals’ understanding and use of medications in Southern Taiwan
  87. Correlation of serum calprotectin with outcome of acute cerebral infarction
  88. Comparison of computed tomography and guided bronchoscopy in the diagnosis of pulmonary nodules: A systematic review and meta-analysis
  89. Curdione protects vascular endothelial cells and atherosclerosis via the regulation of DNMT1-mediated ERBB4 promoter methylation
  90. The identification of novel missense variant in ChAT gene in a patient with gestational diabetes denotes plausible genetic association
  91. Molecular genotyping of multi-system rare blood types in foreign blood donors based on DNA sequencing and its clinical significance
  92. Exploring the role of succinyl carnitine in the association between CD39⁺ CD4⁺ T cell and ulcerative colitis: A Mendelian randomization study
  93. Dexmedetomidine suppresses microglial activation in postoperative cognitive dysfunction via the mmu-miRNA-125/TRAF6 signaling axis
  94. Analysis of serum metabolomics in patients with different types of chronic heart failure
  95. Diagnostic value of hematological parameters in the early diagnosis of acute cholecystitis
  96. Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease
  97. Decrease in CD4 and CD8 lymphocytes are predictors of severe clinical picture and unfavorable outcome of the disease in patients with COVID-19
  98. METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2
  99. The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors
  100. Exploring cerebrospinal fluid metabolites, cognitive function, and brain atrophy: Insights from Mendelian randomization
  101. Development and validation of potential molecular subtypes and signatures of ocular sarcoidosis based on autophagy-related gene analysis
  102. Widespread venous thrombosis: Unveiling a complex case of Behçet’s disease with a literature perspective
  103. Uterine fibroid embolization: An analysis of clinical outcomes and impact on patients’ quality of life
  104. Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head
  105. Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
  106. Enhancing chronic back pain management: A comparative study of ultrasound–MRI fusion guidance for paravertebral nerve block
  107. Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
  108. Electroacupuncture-induced reduction of myocardial ischemia–reperfusion injury via FTO-dependent m6A methylation modulation
  109. Hemorrhoids and cardiovascular disease: A bidirectional Mendelian randomization study
  110. Cell-free adipose extract inhibits hypertrophic scar formation through collagen remodeling and antiangiogenesis
  111. HALP score in Demodex blepharitis: A case–control study
  112. Assessment of SOX2 performance as a marker for circulating cancer stem-like cells (CCSCs) identification in advanced breast cancer patients using CytoTrack system
  113. Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study
  114. Comparison of the two intestinal anastomosis methods in pediatric patients
  115. Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer
  116. Endotoxin tolerance inhibits NLRP3 inflammasome activation in macrophages of septic mice by restoring autophagic flux through TRIM26
  117. Lateral transperitoneal laparoscopic adrenalectomy: A single-centre experience of 21 procedures
  118. Petunidin attenuates lipopolysaccharide-induced retinal microglia inflammatory response in diabetic retinopathy by targeting OGT/NF-κB/LCN2 axis
  119. Procalcitonin and C-reactive protein as biomarkers for diagnosing and assessing the severity of acute cholecystitis
  120. Factors determining the number of sessions in successful extracorporeal shock wave lithotripsy patients
  121. Development of a nomogram for predicting cancer-specific survival in patients with renal pelvic cancer following surgery
  122. Inhibition of ATG7 promotes orthodontic tooth movement by regulating the RANKL/OPG ratio under compression force
  123. A machine learning-based prognostic model integrating mRNA stemness index, hypoxia, and glycolysis‑related biomarkers for colorectal cancer
  124. Glutathione attenuates sepsis-associated encephalopathy via dual modulation of NF-κB and PKA/CREB pathways
  125. FAHD1 prevents neuronal ferroptosis by modulating R-loop and the cGAS–STING pathway
  126. Association of placenta weight and morphology with term low birth weight: A case–control study
  127. Investigation of the pathogenic variants induced Sjogren’s syndrome in Turkish population
  128. Nucleotide metabolic abnormalities in post-COVID-19 condition and type 2 diabetes mellitus patients and their association with endocrine dysfunction
  129. TGF-β–Smad2/3 signaling in high-altitude pulmonary hypertension in rats: Role and mechanisms via macrophage M2 polarization
  130. Ultrasound-guided unilateral versus bilateral erector spinae plane block for postoperative analgesia of patients undergoing laparoscopic cholecystectomy
  131. Profiling gut microbiome dynamics in subacute thyroiditis: Implications for pathogenesis, diagnosis, and treatment
  132. Delta neutrophil index, CRP/albumin ratio, procalcitonin, immature granulocytes, and HALP score in acute appendicitis: Best performing biomarker?
  133. Anticancer activity mechanism of novelly synthesized and characterized benzofuran ring-linked 3-nitrophenyl chalcone derivative on colon cancer cells
  134. H2valdien3 arrests the cell cycle and induces apoptosis of gastric cancer
  135. Prognostic relevance of PRSS2 and its immune correlates in papillary thyroid carcinoma
  136. Association of SGLT2 inhibition with psychiatric disorders: A Mendelian randomization study
  137. Motivational interviewing for alcohol use reduction in Thai patients
  138. Luteolin alleviates oxygen-glucose deprivation/reoxygenation-induced neuron injury by regulating NLRP3/IL-1β signaling
  139. Polyphyllin II inhibits thyroid cancer cell growth by simultaneously inhibiting glycolysis and oxidative phosphorylation
  140. Relationship between the expression of copper death promoting factor SLC31A1 in papillary thyroid carcinoma and clinicopathological indicators and prognosis
  141. CSF2 polarized neutrophils and invaded renal cancer cells in vitro influence
  142. Proton pump inhibitors-induced thrombocytopenia: A systematic literature analysis of case reports
  143. The current status and influence factors of research ability among community nurses: A sequential qualitative–quantitative study
  144. OKAIN: A comprehensive oncology knowledge base for the interpretation of clinically actionable alterations
  145. The relationship between serum CA50, CA242, and SAA levels and clinical pathological characteristics and prognosis in patients with pancreatic cancer
  146. Identification and external validation of a prognostic signature based on hypoxia–glycolysis-related genes for kidney renal clear cell carcinoma
  147. Engineered RBC-derived nanovesicles functionalized with tumor-targeting ligands: A comparative study on breast cancer targeting efficiency and biocompatibility
  148. Relationship of resting echocardiography combined with serum micronutrients to the severity of low-gradient severe aortic stenosis
  149. Effect of vibration on pain during subcutaneous heparin injection: A randomized, single-blind, placebo-controlled trial
  150. The diagnostic performance of machine learning-based FFRCT for coronary artery disease: A meta-analysis
  151. Comparing biofeedback device vs diaphragmatic breathing for bloating relief: A randomized controlled trial
  152. Serum uric acid to albumin ratio and C-reactive protein as predictive biomarkers for chronic total occlusion and coronary collateral circulation quality
  153. Multiple organ scoring systems for predicting in-hospital mortality of sepsis patients in the intensive care unit
  154. Single-cell RNA sequencing data analysis of the inner ear in gentamicin-treated mice via intraperitoneal injection
  155. Review Articles
  156. The effects of enhanced external counter-pulsation on post-acute sequelae of COVID-19: A narrative review
  157. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments
  158. Microscopic changes and gross morphology of placenta in women affected by gestational diabetes mellitus in dietary treatment: A systematic review
  159. Review of mechanisms and frontier applications in IL-17A-induced hypertension
  160. Research progress on the correlation between islet amyloid peptides and type 2 diabetes mellitus
  161. The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis
  162. The application of augmented reality in robotic general surgery: A mini-review
  163. The effect of Greek mountain tea extract and wheat germ extract on peripheral blood flow and eicosanoid metabolism in mammals
  164. Neurogasobiology of migraine: Carbon monoxide, hydrogen sulfide, and nitric oxide as emerging pathophysiological trinacrium relevant to nociception regulation
  165. Plant polyphenols, terpenes, and terpenoids in oral health
  166. Laboratory medicine between technological innovation, rights safeguarding, and patient safety: A bioethical perspective
  167. End-of-life in cancer patients: Medicolegal implications and ethical challenges in Europe
  168. The maternal factors during pregnancy for intrauterine growth retardation: An umbrella review
  169. Intra-abdominal hypertension/abdominal compartment syndrome of pediatric patients in critical care settings
  170. PI3K/Akt pathway and neuroinflammation in sepsis-associated encephalopathy
  171. Screening of Group B Streptococcus in pregnancy: A systematic review for the laboratory detection
  172. Giant borderline ovarian tumours – review of the literature
  173. Leveraging artificial intelligence for collaborative care planning: Innovations and impacts in shared decision-making – A systematic review
  174. Cholera epidemiology analysis through the experience of the 1973 Naples epidemic
  175. Risk factors of frailty/sarcopenia in community older adults: Meta-analysis
  176. Supplement strategies for infertility in overweight women: Evidence and legal insights
  177. Scurvy, a not obsolete disorder: Clinical report in eight young children and literature review
  178. A meta-analysis of the effects of DBS on cognitive function in patients with advanced PD
  179. Protective role of selenium in sepsis: Mechanisms and potential therapeutic strategies
  180. Strategies for hyperkalemia management in dialysis patients: A systematic review
  181. C-reactive protein-to-albumin ratio in peripheral artery disease
  182. Case Reports
  183. Delayed graft function after renal transplantation
  184. Semaglutide treatment for type 2 diabetes in a patient with chronic myeloid leukemia: A case report and review of the literature
  185. Diverse electrophysiological demyelinating features in a late-onset glycogen storage disease type IIIa case
  186. Giant right atrial hemangioma presenting with ascites: A case report
  187. Laser excision of a large granular cell tumor of the vocal cord with subglottic extension: A case report
  188. EsoFLIP-assisted dilation for dysphagia in systemic sclerosis: Highlighting the role of multimodal esophageal evaluation
  189. Molecular hydrogen-rhodiola as an adjuvant therapy for ischemic stroke in internal carotid artery occlusion: A case report
  190. Coronary artery anomalies: A case of the “malignant” left coronary artery and its surgical management
  191. Rapid Communication
  192. Biological properties of valve materials using RGD and EC
  193. A single oral administration of flavanols enhances short-term memory in mice along with increased brain-derived neurotrophic factor
  194. Letter to the Editor
  195. Role of enhanced external counterpulsation in long COVID
  196. Expression of Concern
  197. Expression of concern “A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma”
  198. Expression of concern “Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway”
  199. Expression of concern “circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8”
  200. Corrigendum
  201. Corrigendum to “Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism”
  202. Corrigendum to “Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis”
  203. Corrigendum to “The progress of autoimmune hepatitis research and future challenges”
  204. Retraction
  205. Retraction of “miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway”
  206. Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424”
  207. Retraction of: “SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways”
  208. Special Issue Advancements in oncology: bridging clinical and experimental research - Part II
  209. Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
  210. Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells
  211. The era of increasing cancer survivorship: Trends in fertility preservation, medico-legal implications, and ethical challenges
  212. Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ
  213. Meta-analysis of clinical efficacy and safety of immunotherapy combined with chemotherapy in non-small cell lung cancer
  214. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part IV
  215. Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development
  216. Special Issue The evolving saga of RNAs from bench to bedside - Part III
  217. Interaction and verification of ferroptosis-related RNAs Rela and Stat3 in promoting sepsis-associated acute kidney injury
  218. The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer
  219. Special Issue Exploring the biological mechanism of human diseases based on MultiOmics Technology - Part II
  220. Dynamic changes in lactate-related genes in microglia and their role in immune cell interactions after ischemic stroke
  221. A prognostic model correlated with fatty acid metabolism in Ewing’s sarcoma based on bioinformatics analysis
  222. Red cell distribution width predicts early kidney injury: A NHANES cross-sectional study
  223. Special Issue Diabetes mellitus: pathophysiology, complications & treatment
  224. Nutritional risk assessment and nutritional support in children with congenital diabetes during surgery
  225. Correlation of the differential expressions of RANK, RANKL, and OPG with obesity in the elderly population in Xinjiang
  226. A discussion on the application of fluorescence micro-optical sectioning tomography in the research of cognitive dysfunction in diabetes
  227. A review of brain research on T2DM-related cognitive dysfunction
  228. Metformin and estrogen modulation in LABC with T2DM: A 36-month randomized trial
  229. Special Issue Innovative Biomarker Discovery and Precision Medicine in Cancer Diagnostics
  230. CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms
Downloaded on 25.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2025-1299/html?lang=en
Scroll to top button